See All Slides -

Slides

Presentation TCT 2021

REDEFINE: A Prospective, Randomized Evaluation of the ControlRad System to Reduce Radiation Exposure During Cardiac Catheterization Procedures

Presenter: Simon Dixon

November 05, 2021

Presentation TCT 2021

Disrupt CAD III 1yr Data

Presenter: Matthew Price

November 05, 2021

Presentation TCT 2021

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

Presenter: NULL

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Introduction & MOA Overview

Presenter: Ziad Ali

November 05, 2021

Presentation TCT 2021

Electroanatomical Navigation for Arterial Stenting with Near-Zero X-Ray or Iodine-Based Contrast Medium: Insights from Experimental Data

Presenter: Jean-Francois Dorval

November 05, 2021

Presentation TCT 2021

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Sandeep Nathan

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TCT 2021

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Arthur Reshad Garan

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Advertisement

Slides

REDEFINE: A Prospective, Randomized Evaluation of the ControlRad System to Reduce Radiation Exposure During Cardiac Catheterization Procedures

Disrupt CAD III 1yr Data

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Introduction & MOA Overview

Electroanatomical Navigation for Arterial Stenting with Near-Zero X-Ray or Iodine-Based Contrast Medium: Insights from Experimental Data

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content